phosphorylase/infarction

BACKGROUND Much of the clinical practice of oncology involves palliative care. In this setting ,the emphasis is on alleviation of symptoms and preservation or improvement of quality of life. A large body of clinical evidence documents the effectiveness of local-field external beam radiotherapy in

OUTLINE: This is a multi-center study. CAPOX (21 day cycle): - Capecitabine 825 mg/m2 orally twice daily Days 1-14. - Oxaliplatin 100 mg/m2 intravenously Day 1 Patients may continue combination therapy until progression or toxicity intervenes. Patients who discontinue either agent due to toxicity

OUTLINE: This is a multi-center study. - CAPOX-T (21 day cycle):Capecitabine 825 mg/m2 orally twice daily Days 1-14Oxaliplatin 100 mg/m2 intravenously Day 1 - Trastuzumab : 6 mg/kg intravenously Day 1.8mg/kg loading dose should be given in cycle 1 for patients without previous trastuzumab therapy